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ABSTRACT 
 
In order to evaluate the protective effect of verapamil against hexachlorobutadiene (HCBD) 
nephrotoxicity, 30 adult Wistar albino rats were divided into five equal groups, A, B, C, D and E and were 
given intra-peritonially corn oil (I ml/kg; control), HCBD (50 mg/kg), verapamil (50 µg/kg) with HCBD 
(50 mg/kg), verapamil (100 µg/kg) with HCBD (50 mg/kg) and verapamil (100 µg/kg) with HCBD (100 
mg/kg), respectively. Verapamil was given one hour before HCBD treatment. All animals were killed after 
24 hours. Serum concentrations of urea and creatinine were higher (P<0.05) in HCBD-treated rats 
compared with the controls, as well as verapamil treated groups. Histopathological examination of kidneys 
showed substantial necrosis in straight portion of the proximal tubules in HCBD treated rats. In verapamil-
treated groups, kidneys appeared normal. It was concluded that verapamil can protect kidneys against toxic 
effects of HCBD in rats.  
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INTRODUCTION 
 
Calcium is an important mediator of cell death in 
xenobiotic-induced cell injury. Alterations in intra-
cellular calcium levels play an important role in the 
cysteine conjugate induced cell death. Some studies 
have shown that calcium channel blockers, such as 
verapamil, protect kidneys against nephrotoxins such as 
mercuric chloride (Girardi and Elias, 1998), gentamycin 
(Ali  et al., 2002), cisplatin (Sleijfer et al., 1987), 
cephalosporins (Browning, 1990), and cyclosporine 
(Koo et al., 2003). This paper presents the results about 
the protective effect of verapamil against HCBD 
nephrotoxicity in rats. 
 
MATERIALS AND METHODS 
 
In this study, 30 adult Wistar albino rats of either 
sex, weighing 150-200g, were used. They were kept 
under 12 hour light/dark cycle at 20ºC and 50% 
humidity. After acclimatization, they were randomly 
divided into five equal groups, i.e. A, B, C, D and E. 
These rats received single dose of the respective 
treatment via intraperitonial route, as shown in Table 1.  
All animals were killed under light ether anesthesia 
24 hours after treatment. Blood samples collected from 
each rat were used for the determination of urea and 
creatinine concentrations, using Technicon RA-1000 
Autoanalyser. The right kidney of each rat was 
removed and fixed in 10% neutral buffered formalin, 
sectioned at 5 µm and processed for Haematoxylin and 
Eosin staining for histopathological studies. The data on 
serum urea and creatinine concentrations were analyzed 
using one-way analysis of variance and Tukey’s test. 
 
RESULTS AND DISCUSSION 
 
Rats of group B treated with HCBD alone showed 
significantly higher serum urea and creatinine 
concentrations compared to control (corn oil) and 
verapamil treated groups (Table 2). However, non 
significant difference was observed between corn oil 
and verapamil treated groups. 
In control and verapamil treated groups,   
glomerulus, Bowman’s capsule, proximal, distal and 
collecting tubules of kidneys appeared normal histo- 
logically. However, in HCBD treated group, an 
extensive damage in straight portion of proximal tubule 
was observed. Other parts of kidney, including cortex 
and medulla, appeared normal.  
 
Table 1: Protocol of treatments for rats of five 
groups 
 
Group Treatment detail 
A  Control: corn oil (1 ml/kg) 
B HCBD  (50  mg/kg) 
C  Verapamil (50 µg/kg) one hour before  
HCBD (50 mg/kg) 
D  Verapamil (100 µg/kg) one hour before  
HCBD (50 mg/kg) 
E  Verapamil (100 µg/kg) one hour before 
HCBD (100 mg/kg) Pakistan Vet. J., 2008, 28(4): 201-202. 
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Table 2: Serum urea and creatinine concentrations in rats treated with various doses of HCBD with and 
without verapamil  
Groups Urea  (mg/dL)  Creatinine (mg/dL) 
A: Corn oil (1ml/kg; control)  33.8 ± 1.3a  0.53 ± 0.05a 
B: HCBD (50 mg/kg)  81.7 ± 4.7b  1.08 ± 0.30b 
C: Verapamil (50 µg/kg) with HCBD (50 mg/kg)  40.3 ± 1.1a  0.53 ± 0.05a 
D: Verapamil (100 µg/kg) with HCBD (50 mg/kg)  38.0 ± 5.4a  0.50 ± 0.01a 
E: Verapamil (100 µg/kg) with HCBD (100 mg/kg)  44.8 ± 6.2a  0.60 ± 0.01a 
Values bearing different letters in a column differ significantly (P<0.05). 
 
These results showed that verapamil has a 
protective effect against HCBD-induced nephrotoxicity 
in rats. HCBD is a potent nephrotoxin which can cause 
degeneration, necrosis, and regeneration in renal tubular 
epithelial cells (Berndt and Mehendale, 1979; Kirby 
and Bach, 1995). Its toxicity is due to its conjugation 
with glutathione to form glutathione S-conjugate, and 
finally to the related cysteine-conjugate. This meta- 
bolite is then actively taken up by kidneys and cleared 
through the renal tubular epithelial cells as a reactive 
thiol derivative by the enzyme-lyase, which covalently 
binds to macromolecules (Schrenk and Dekant, 1989). 
The S3 region (pars recta) of the proximal tubule of 
rat’s kidney is the most susceptible organ to the 
nephrotoxicity induced by cysteine-conjugates.   
Calcium has been shown to have an important role 
in cellular toxicity (Ali et al., 2002). As calcium 
homeostasis is precisely controlled, any alteration in 
intracellular calcium level could play an important role 
in the cysteine conjugate-induced cell death. Thus, 
calcium channel blockers like verapamil may affect the 
role of calcium in cellular toxicity. Toxicological 
consequences of increased intracellular calcium 
concentration could be: i) activation of calpains, leading 
to disruption of the protein components of cytoskeleton, 
ii) activation of Ca-dependent endonuclease, resulting 
in DNA single and double strand breaks and apoptotic 
or necrotic cell death, iii) activation of Ca-dependent 
phospholipases, causing liberation of arachidonic acid 
and disruption of membrane integrity with ensuing cell 
death, and iv) activation of gene expression (Watson et 
al., 1987). The mechanism(s) for protective effect of 
verapamil is not clear, but may be mediated by: a) 
enhancing elimination of HCBD and/or its toxic 
metabolite, b) inhibiting the activation of Ca-dependent 
proteases (calpains), endonucleases and phospholipases, 
c) improving renal blood flow due to vasodilatory 
effect, which will reduce toxicity and d) preventing 
gene expression (Ali et al., 2002). 
Several investigations have been carried out on the 
role of calcium channel blockers against nephrotoxicity 
of mercuric chloride (Ali et al., 2002), gentamycin 
(Watson et al., 1987), cephalosporines (Sleijfer et al., 
1987), cyclosporine (Koo et al., 2003) cadmium 
(Browning, 1990) and cisplatin (Sleijfer et al., 1987). 
Verapamil can protect kidneys against mercuric 
chloride toxicity. Animals treated with verapamil (75 
µg/kg, i.p) prior to mercuric chloride showed normal 
kidney appearance (Girardi and Elias, 1998).  
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